Balanced news tone
News Sentiment
BAX sentiment intelligence
Baxter International Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-0.1% over one week, +8.4% over four weeks, trend active, and below fair value.
Baxter stock holds steady as restructuring and spin-off reshape the portfolio
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Baxter stock holds steady as restructuring and spin-off reshape the portfolio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 17:46
- Source
- Ad Hoc News
Baxter International Updates Segment Reporting Structure and Metrics
Baxter International (BAX) has reorganized its reporting structure into two segments: Medical Products & Therapies and Healthcare Systems & Technologies, effective for the quarter ended June 30, 2026. This change aims to improve decision-making and performance assessment. The com
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 09:07
- Source
- The Globe and Mail
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing
This article analyzes Baxter International Inc. (BAX) using AI-generated signals and multi-timeframe analysis to guide rotational strategy timing. It notes weak near-term sentiment but strong mid-term prospects within a broader weak long-term bias. The analysis provides specific
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 21:58
- Source
- Stock Traders Daily
Baxter International Inc. stock outperforms competitors on strong trading day
Shares of Baxter International Inc. (BAX) increased by 1.61% to $22.15, outperforming the broader market on a strong trading day. The S&P 500 Index (SPX) rose by 0.38% and the Dow Jones Industrial Average (DJIA) gained 0.29%. This rally ended a two-day losing streak for the stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 21:15
- Source
- MarketWatch
Is Baxter’s Class I Respiratory Device Recall Reshaping the Investment Case for Baxter International (BAX)?
Baxter Healthcare has issued a voluntary FDA Class I recall for its Hillrom VOLARA System circuit kits due to nebulizer cup leakage, which could lead to oxygen level drops and ineffective treatment. This high-severity recall, affecting over 10,540 units, raises concerns about Bax
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 15 Jul 2026 17:46
- Source
- Simply Wall Street
Press Release: Biogen Appoints Michael J. Parini as Chief Legal Officer
Biogen has announced the appointment of Michael J. Parini as its new Chief Legal Officer, effective August 10, replacing Susan Alexander who is retiring. Parini brings extensive experience from his previous roles at Zimmer Biomet, Baxalta, and Baxter, and will be responsible for
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 12:37
- Source
- Moomoo
AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap
This article analyzes a "golden cross" technical signal for both AbbVie (ABBV) and Baxter International (BAX), evaluating which stock is better suited for an income-focused retirement portfolio. It concludes that AbbVie is a clear winner due to its robust dividend, strong financi
- Tone
- Negative 19/100
- Event
- Capital return
- Published
- 15 Jul 2026 11:46
- Source
- 24/7 Wall St.
A Look at Baxter International Inc (BAX) After 3.4% Decline -- G
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 22:47
- Source
- GuruFocus
Baxter reorganizes to two segments, recasts prior-period segment results and discloses operational/organic sales metrics
Baxter has reorganized its reporting structure from three segments to two: Medical Products & Therapies and Healthcare Systems & Technologies. This change involves recasting prior-period financials for comparability, including moving the former Pharmaceuticals segment and updatin
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 20:23
- Source
- TradingView
Baxter (NYSE: BAX) recasts 2025 segment sales and shows $505M loss
Baxter International Inc. has reorganized its reporting structure into two segments, Medical Products & Therapies (MPT) and Healthcare Systems & Technologies (HST), starting Q2 2026. The company provided recast financial data for 2024-2025 and recent quarters to align with this n
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 14 Jul 2026 20:16
- Source
- Stock Titan
Baxter International Inc. stock outperforms competitors despite losses on the day
Baxter International Inc. (BAX) experienced a 3.41% drop in its stock price, closing at $21.80 on Tuesday. Despite this loss, the stock still outperformed competitors on a day when the broader market saw gains, with the S&P 500 Index rising 0.38% and the Dow Jones Industrial Aver
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 14 Jul 2026 17:15
- Source
- MarketWatch
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating
Goldman Sachs has increased its price target for Baxter International (BAX) to $21 from $19, while maintaining a Neutral rating on the stock. This adjustment reflects an updated valuation by the financial institution.
- Tone
- Positive 59/100
- Event
- Analyst action
- Published
- 14 Jul 2026 11:37
- Source
- Moomoo
ETFs Investing in Baxter International Inc. Stocks
This article lists various ETFs that include Baxter International Inc. (BAX) stocks in their holdings. The detailed table provides information on each fund, such as market value, weight of BAX in the fund, issuer, management style, focus, expense ratio, assets under management (A
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 06:17
- Source
- TradingView
Baxter stock reflects a diversified medical technology business
The article highlights Baxter International Inc. as a global medical technology company offering a diversified portfolio across hospital products, renal care, and advanced infusion systems. It emphasizes Baxter's broad exposure to healthcare demand through essential clinical solu
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 10 Jul 2026 16:59
- Source
- Ad Hoc News
Baxter International stock reflects a diversified medical portfolio and ongoing portfolio transforma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:55
- Source
- Ad Hoc News
Baxter International Inc. (BAX) Stock Price | Live Quotes & Charts | NYSE
This page provides live stock quotes and charts for Baxter International Inc. (BAX) on the NYSE, showing its current price and daily change. It notes that there is no analyst rating or earnings information available for BAX, and encourages users to get real-time quotes. The page
- Tone
- Negative 39/100
- Event
- Analyst action
- Published
- 09 Jul 2026 22:37
- Source
- timothysykes.com
Baxter Beats Stable Value Fund 401(k) Plan Suit, For Good
Baxter International has successfully defeated a proposed class action lawsuit arguing that the low returns of its employee retirement plan were evidence of mismanagement. An Illinois federal judge ruled in favor of Baxter, permanently settling the case. The lawsuit, Clinton v. B
- Tone
- Positive 72/100
- Event
- Regulatory and legal
- Published
- 09 Jul 2026 21:07
- Source
- Law360
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX) will host a conference call on Thursday, July 30, 2026, at 7:30 a.m. Central Time, to discuss its second-quarter 2026 financial results. Investors and interested parties can pre-register for the call or access the webcast through the company's
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jul 2026 20:07
- Source
- Business Wire
Retia Medical Adds Former Baxter Executive Christopher Benassi to Advisory Board
Retia Medical has appointed Christopher Benassi, former vice president of Baxter International’s Connected Care Group, to its Strategic Advisory Board. This appointment comes as Retia Medical expands the commercialization of its Argos Infinity™ cardiovascular intelligence softwar
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 16:07
- Source
- citybiz
Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh
This article provides financial information for Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh (B1AX34) on TradingView. It specifically highlights the "Enterprise value to EBITDA forward" metric for the company. The content appears to be a stub
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 11:42
- Source
- TradingView
Baxter International (BAX) Is Up 7.2% After Dual Russell 2500 Index Additions - What's Changed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 12:40
- Source
- simplywall.st
Baxter International's Q2 2026 Earnings: What to Expect
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 11:14
- Source
- Barchart
Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Market source
Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Market source
Baxter International focuses on core portfolio as investors weigh long-term growth prospects
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 15:46
- Source
- Ad Hoc News
Baxter International outlines its healthcare focus as investors watch the stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 17:39
- Source
- Ad Hoc News
Is Baxter International Stock Underperforming the S&P 500?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Market source
Reasons to Retain Baxter International Stock in Your Portfolio for Now
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Baxter International (BAX) Stock Valuation Check After Recent Double Digit Gains And Ongoing Turnaround Plans
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- Market source
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- Market source